GammaDelta Therapeutics Ltd.

https://www.gammadeltatx.com

GammaDelta Therapeutics (“GammaDelta”) is clinically-staged biotechnology company pioneering the discovery and development of allogeneic gamma delta T cell therapies for cancer. Committed to transforming the treatment of patients living with cancer, the Company is developing an ‘off-the-shelf’ therapy based on one of the body’s own immune cells, a subtype of the gamma delta (?d) T-lymphocyte, known as the Vd1+ T cell. The Company has developed proprietary technologies to generate both blood-and tissue-derived allogeneic immunotherapies based on Vd1 ?d T cells for the treatment of hematological malignancies and solid tumors. Both platforms have enabled the creation of non-engineered and genetically engineered allogeneic cell therapies, which demonstrate cellular activity and tumor cell killing capacity in pre-clinical models. GammaDelta is advancing its novel, ?d T cell platforms and product candidates under an ongoing collaboration with Takeda Pharmaceutical Company Limited (“Takeda”). GammaDelta’s technologies are based on pioneering world-class research conducted by Professor Adrian Hayday and Dr Oliver Nussbaumer, at King’s College London and the Francis Crick Institute, and Professor Bruno Silva-Santos at the University of Lisbon. Early-stage research was facilitated in part by the support and the infrastructure of the National Institute for Health Research Guy’s and St Thomas’ Biomedical Research Centre. The formation of GammaDelta as a company was supported by Cancer Research UK Commercial Partnerships. GammaDelta’s technologies have attracted significant investment from Takeda and leading life sciences investor, Abingworth LLP. *

	Start	2016-06-17 established
	Industry	T cell therapy
	Industry 2	cancer immunotherapy (immuno-oncology, I-O)
	Person	Paoletti, Paolo (GammaDelta Therapeutics 201705– CEO before Kesios Therapeutics CEO + GSK)
	Person 2	Haines, Timothy (Tim) (Abingworth 201507– Managing Partner joined 2005 before Astex CEO)

	Region	London, Greater London
	Country	United Kingdom (GB)
	Street	195 Wood Lane The Westworks, White City Place
	City	W12 7FQ London
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: GammaDelta Therapeutics Ltd.. (10/27/21). "Press Release: Takeda to Acquire GammaDelta Therapeutics to Accelerate Development of Allogeneic gdT Cell Therapies Addressing Solid Tumors". Osaka & London.

		Record changed: 2024-06-07